Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT06102733
Recruiting Observational

Chronic Pelvic Pain in Females and Males

NCT06102733 · tracked via the Priya Life Science Canada tracker
Sponsor
Salem Anaesthesia Pain Clinic
Phase
Observational
Started
2018-01-02
Last updated
2025-01-27

Condition(s) studied

Pelvic Pain SyndromeSacroiliac DisorderPiriformis SyndromeSacrococcygeal DisorderInguinal Hernia

Investigational drug(s) / intervention(s)

Rehabilitation therapy

Rehabilitation therapy: Chronic pain rehabilitation therapy

Study summary

Pelvic pain is under-reported in healthy adults. Many patients with pelvic pain under-estimate the problem. Chronic pelvic pain can be managed properly, if diagnosed promptly.

This is a quantitative analysis of prospective clinical data. It evaluates the management of pelvic pain in a cohort population, and analyzes the treatment outcome.

Eligibility

Sex
ALL
Min age
20 Years
Max age
99 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with chronic pelvic pain * Patients with sacroiliac pain * Patients with inguinal pain * Patients with coccygeal pain * Patients with piriformis pain Exclusion Criteria: * Patients with spinal pain * Patients who had spine surgery

Primary outcome measure(s)

  • Pain score, objective measurement using the validated Numeric Pain Rating scale — 12 months
    Pain score, using the Numeric Pain Rating scale of 0 to 10, low scores indicate less pain, high scores indicate worse pain

Trial sites (1)

FacilityCityRegionStatus
Salem Anaesthesia Pain Clinic Surrey British Columbia Recruiting

More Salem Anaesthesia Pain Clinic trials in Canada

Pain Clinic Provides Public Health Safety Recruiting
Discrimination Harassment of Pain Staff Caused by Patient Recruiting
Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise Recruiting
Characteristics of Injury Claims by Chronic Pain Patients Recruiting
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients Recruiting

Other trials for the same condition

No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair Active, not recruiting
Perioperative Rehab for Inguinal Hernia Repair Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06102733 on ClinicalTrials.gov ↗ ← All trials in Canada